Imunon, Inc. — Director's Dealing 2011

Dec 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-12-06

Reporting Person: Martinez Alberto R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-06	Celsion Corporation Common Stock	P	5000	$2.3125	Acquired	74125	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-06	Warrant to purchase Common Stock	$2.36	P	2500	Acquired	2016-12-06	Celsion Corporation Common Stock (2500)	Direct

Footnotes

F1: The securities were purchased in a private placement transaction (the "Private Placement") completed December 6, 2011 between Celsion Corporation and qualified institutional investors as well as two directors of Celsion Corporation.

F2: In the Private Placement, the Company sold units, each consisting of one share of the Company's common stock and a warrant to purchase 0.5 shares of the Company's common stock, at a price of $2.3125 per unit.